{"id":45989,"date":"2025-11-06T14:07:02","date_gmt":"2025-11-06T06:07:02","guid":{"rendered":"https:\/\/flcube.com\/?p=45989"},"modified":"2025-11-06T14:07:02","modified_gmt":"2025-11-06T06:07:02","slug":"siemens-shanghai-gains-nmpa-clearance-for-prostate%e2%80%91cancer-ai-detection-software","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=45989","title":{"rendered":"Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software"},"content":{"rendered":"\n<p><strong>Siemens Shanghai Medical Equipment Ltd. (SSME)<\/strong> announced that the <strong>National Medical Products Administration (NMPA)<\/strong> has granted marketing authorization for its <strong>Prostate Cancer Magnetic Resonance Image\u2011Assisted Detection Software<\/strong> (AI\u2011PC\u2011MRI). The AI\u2011driven solution is the first deep\u2011learning\u2011based tool approved in China to assist radiologists in identifying suspected prostate adenocarcinoma in treatment\u2011na\u00efve men aged\u202f40\u202fyears and older.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-product-overview\">Product Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Feature<\/th><th>Description<\/th><\/tr><\/thead><tbody><tr><td><strong>Technology<\/strong><\/td><td>Deep\u2011learning artificial intelligence (AI) engine trained on &gt;\u202f10,000 annotated prostate MRI studies<\/td><\/tr><tr><td><strong>Functions<\/strong><\/td><td>Image display, preprocessing, quantitative measurement, lesion segmentation, and risk scoring<\/td><\/tr><tr><td><strong>Indication<\/strong><\/td><td>Detection of suspected prostate adenocarcinoma lesions in untreated adult patients (\u2265\u202f40\u202fy)<\/td><\/tr><tr><td><strong>Clinical Benefit<\/strong><\/td><td>Improves radiologist interpretation accuracy; reduces unnecessary biopsies by up to 25\u202f% in early\u2011stage trials<\/td><\/tr><tr><td><strong>Regulatory Status<\/strong><\/td><td>NMPA registration approved 5\u202fNov\u202f2025; CE\u2011marked in the EU since 2023<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact\">Market Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Competitive Edge<\/strong> \u2013 Siemens joins a limited group of AI\u2011enabled imaging vendors with Chinese regulatory clearance, positioning it ahead of domestic rivals that rely on rule\u2011based algorithms.<\/li>\n\n\n\n<li><strong>Revenue Upside<\/strong> \u2013 The software is sold under a <strong>software\u2011as\u2011a\u2011service (SaaS)<\/strong> model, generating recurring fees (~\u202fRMB\u202f3,000 per hospital per month). Early adoption forecasts suggest <strong>\u00a5120\u202fmillion<\/strong> in annual recurring revenue by 2027.<\/li>\n\n\n\n<li><strong>Healthcare Efficiency<\/strong> \u2013 By flagging high\u2011risk lesions and streamlining workflow, the tool supports China\u2019s \u201cHealthy China 2030\u201d initiative to lower overtreatment and improve early cancer detection.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-clinical-workflow-integration\">Clinical Workflow Integration<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>MRI Acquisition<\/strong> \u2013 Standard multiparametric prostate MRI performed on 3\u202fT scanners.<\/li>\n\n\n\n<li><strong>AI Processing<\/strong> \u2013 Images uploaded to the Siemens cloud platform; AI algorithm automatically segments prostate zones and highlights suspicious lesions.<\/li>\n\n\n\n<li><strong>Radiologist Review<\/strong> \u2013 Clinician reviews AI\u2011generated heat maps, adjusts measurements, and assigns a PI\u2011RADS\u2011like score.<\/li>\n\n\n\n<li><strong>Decision Support<\/strong> \u2013 Integrated recommendation engine suggests biopsy necessity, helping to avoid unnecessary procedures.<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-outlook-amp-next-steps\">Outlook &amp; Next Steps<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Post\u2011Market Surveillance<\/strong> \u2013 Siemens will collect real\u2011world performance data through the NMPA\u2019s Medical Device Monitoring System, with quarterly safety reports.<\/li>\n\n\n\n<li><strong>Expansion Plans<\/strong> \u2013 A roadmap includes adding <strong>multiparametric MRI\u2011fusion biopsy guidance<\/strong> and extending the AI engine to <strong>bladder and kidney imaging<\/strong> by 2026.<\/li>\n\n\n\n<li><strong>Strategic Partnerships<\/strong> \u2013 Ongoing talks with major Chinese hospital groups (e.g., Peking University Health Science Center) aim to embed the solution in over <strong>200<\/strong> institutions within the next 12\u202fmonths.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding regulatory status, market adoption, and revenue projections. Actual results may differ due to clinical outcomes, regulatory actions, and competitive dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-2458b084-c83e-47da-ac80-9cb99461df2e\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1762331599122021802.docx\">1762331599122021802<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1762331599122021802.docx\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-2458b084-c83e-47da-ac80-9cb99461df2e\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Siemens Shanghai Medical Equipment Ltd. (SSME) announced that the National Medical Products Administration (NMPA) has&#8230;<\/p>\n","protected":false},"author":1,"featured_media":45991,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[22],"tags":[16,15,223],"class_list":["post-45989","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-device","tag-cancer","tag-product-approvals","tag-siemens-healthineers"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Siemens Shanghai Medical Equipment Ltd. (SSME) announced that the National Medical Products Administration (NMPA) has granted marketing authorization for its Prostate Cancer Magnetic Resonance Image\u2011Assisted Detection Software (AI\u2011PC\u2011MRI). The AI\u2011driven solution is the first deep\u2011learning\u2011based tool approved in China to assist radiologists in identifying suspected prostate adenocarcinoma in treatment\u2011na\u00efve men aged\u202f40\u202fyears and older.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=45989\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software\" \/>\n<meta property=\"og:description\" content=\"Siemens Shanghai Medical Equipment Ltd. (SSME) announced that the National Medical Products Administration (NMPA) has granted marketing authorization for its Prostate Cancer Magnetic Resonance Image\u2011Assisted Detection Software (AI\u2011PC\u2011MRI). The AI\u2011driven solution is the first deep\u2011learning\u2011based tool approved in China to assist radiologists in identifying suspected prostate adenocarcinoma in treatment\u2011na\u00efve men aged\u202f40\u202fyears and older.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=45989\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-06T06:07:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0602.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45989#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45989\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software\",\"datePublished\":\"2025-11-06T06:07:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45989\"},\"wordCount\":403,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45989#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0602.webp\",\"keywords\":[\"Cancer\",\"Product approvals\",\"Siemens Healthineers\"],\"articleSection\":[\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45989#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45989\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=45989\",\"name\":\"Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45989#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45989#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0602.webp\",\"datePublished\":\"2025-11-06T06:07:02+00:00\",\"description\":\"Siemens Shanghai Medical Equipment Ltd. (SSME) announced that the National Medical Products Administration (NMPA) has granted marketing authorization for its Prostate Cancer Magnetic Resonance Image\u2011Assisted Detection Software (AI\u2011PC\u2011MRI). The AI\u2011driven solution is the first deep\u2011learning\u2011based tool approved in China to assist radiologists in identifying suspected prostate adenocarcinoma in treatment\u2011na\u00efve men aged\u202f40\u202fyears and older.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45989#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45989\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45989#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0602.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0602.webp\",\"width\":1080,\"height\":608,\"caption\":\"Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45989#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software - Insight, China&#039;s Pharmaceutical Industry","description":"Siemens Shanghai Medical Equipment Ltd. (SSME) announced that the National Medical Products Administration (NMPA) has granted marketing authorization for its Prostate Cancer Magnetic Resonance Image\u2011Assisted Detection Software (AI\u2011PC\u2011MRI). The AI\u2011driven solution is the first deep\u2011learning\u2011based tool approved in China to assist radiologists in identifying suspected prostate adenocarcinoma in treatment\u2011na\u00efve men aged\u202f40\u202fyears and older.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=45989","og_locale":"en_US","og_type":"article","og_title":"Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software","og_description":"Siemens Shanghai Medical Equipment Ltd. (SSME) announced that the National Medical Products Administration (NMPA) has granted marketing authorization for its Prostate Cancer Magnetic Resonance Image\u2011Assisted Detection Software (AI\u2011PC\u2011MRI). The AI\u2011driven solution is the first deep\u2011learning\u2011based tool approved in China to assist radiologists in identifying suspected prostate adenocarcinoma in treatment\u2011na\u00efve men aged\u202f40\u202fyears and older.","og_url":"https:\/\/flcube.com\/?p=45989","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-06T06:07:02+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0602.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=45989#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=45989"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software","datePublished":"2025-11-06T06:07:02+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=45989"},"wordCount":403,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=45989#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0602.webp","keywords":["Cancer","Product approvals","Siemens Healthineers"],"articleSection":["Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=45989#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=45989","url":"https:\/\/flcube.com\/?p=45989","name":"Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=45989#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=45989#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0602.webp","datePublished":"2025-11-06T06:07:02+00:00","description":"Siemens Shanghai Medical Equipment Ltd. (SSME) announced that the National Medical Products Administration (NMPA) has granted marketing authorization for its Prostate Cancer Magnetic Resonance Image\u2011Assisted Detection Software (AI\u2011PC\u2011MRI). The AI\u2011driven solution is the first deep\u2011learning\u2011based tool approved in China to assist radiologists in identifying suspected prostate adenocarcinoma in treatment\u2011na\u00efve men aged\u202f40\u202fyears and older.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=45989#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=45989"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=45989#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0602.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0602.webp","width":1080,"height":608,"caption":"Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=45989#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Siemens Shanghai Gains NMPA Clearance for Prostate\u2011Cancer AI Detection Software"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0602.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45989"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45989\/revisions"}],"predecessor-version":[{"id":45992,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45989\/revisions\/45992"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/45991"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}